TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the "Company" or “Aura”) (CSE: BUZZ) is pleased to announce it has entered into an Investor Relations Agreement (the “Agreement”) to have First Canadian Capital Corp. (“First Canadian”) provide Investor Relations services to Aura for a period of 18 months commencing September 24, 2018.
The Agreement may be Terminated 10 days after the first 6 months from execution, and at any time thereafter subject to 30 days notice.
Compensation for this Agreement consist of a $6,000 per month fee plus Aura issuing an Option to First Canadian to acquire 350,000 shares of the Company to be vested 25% upon the commencement of the contract, and 25% at the end of each 6 months following thereafter.
Aura has also issued an Option to acquire 250,000 shares to its CEO, Daniel Cohen, and an Option for 50,000 shares to Tim Wilkinson who has provided various industry-related business consulting services to the company without other compensation. This is the first Option issued to Mr. Cohen.
The terms of the Options for include a 3-year Term commencing September 21, 2018, and a strike price of 31 cents. The Cohen and Wilkinson Options are deemed fully vested upon the date of issue.
About First Canadian Capital Corp.
First Canadian Capital Corp., (FCC) was founded in 1998 and specializes in providing Investor Relations and Market Awareness services to small-cap and mid-tier public companies. FCC’s core competencies include: identifying well managed, undervalued companies with high growth potential; and, providing effective Investor Relations and Market Awareness services to these companies.
About Aura Health Inc.
Aura, through its wholly-owned Delaware subsidiary, Green Global Properties Inc. ("Green Global"), owns a 30% interest in four medical marijuana clinics in Las Vegas, Nevada; Mesa, Arizona; Tucson, Arizona and Hollywood, Florida, respectively. Green Global has an option to increase its interest in each such clinic (other than the Nevada clinic) to 51%. Aura currently has an LOI in place to acquire a 54% interest in HolyCanna, an Israel-based cultivation and nursery license holder.
For updates on the Company's activities and highlights of the Company's press releases, investor deck and other media coverage, please visit Aura's web site at www.aurahealthinc.com
For further information, please contact:
Daniel Cohen, CEO - (647) 202-1824
David Posner, Director and Chairman - (647) 985-6727
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. Any such forward- looking statements may be identified by words such as "expects", "anticipates", "believes", "projects", "plans" and similar expressions. Forward looking information in this news release includes the following statements: (i) expected trading date on the CSE; (ii) management's belief that the listing on the CSE will increase pool of potential investors and bring other benefits, and (iii) management’s plan to build an international network of vertical integrated businesses in the medical marijuana field.
Certain information contained in this press release constitutes forward-looking information, which is information relating to future events or the Corporation's future performance and which is inherently uncertain. All information other than statements of historical fact may be forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as "seek", "anticipate", "budget", "plan", "continue", "estimate", "expect", "forecast", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe" and similar words or phrases (including negative variations) suggesting future outcomes or statements regarding an outlook. Forward-looking information contained in this press release includes, but is not limited to, final acceptance of the RTO Transaction by CSE and listing of the Corporation's shares. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Corporation believes the expectations reflected in the forward-looking information are reasonable but no assurance can be given that these expectations will prove to be correct and readers are cautioned not to place undue reliance on forward-looking information contained in this press release. Some of the risks and other factors which could cause results to differ materially from those expressed in the forward-looking information contained in this press release include, but are not limited to: the risks that the RTO Transaction and associated transactions will not be accepted by the CSE, and other risks included in the Listing Statement available at www.sedar.com. The forward-looking information contained in this press release is made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as otherwise required by law.